HomeProductsKey IntermediatesAnti-Myeloma Carfilzomib Powder CAS 868540-17-4

Anti-Myeloma Carfilzomib Powder CAS 868540-17-4

$20 - 30 /Gram
10 /Gram (Min. Order)
Payment Type:
T/T,Paypal
Incoterm:
FOB
Min. Order:
10 Gram
Transportation:
Land,Air,Express,Ocean
Port:
Shanghai,Shenzhen,Guangzhou
Share:
Chat Now
  • Product Description
Overview
Product Attributes

Model No.Carfilzomib

BrandRhine

GradePhamaceutical Grade

Place Of OriginChina

Test MethodHPLC UV COA

Specification10g:vial/bag

TrademarkRHINE

Sec-HPLC99.5%

PackageAluminum Foil Bag/Carton/Drum

Cas868540-17-4

MW719.9099

Molecular FormulaC40H57N5O7

Supply Ability & Additional Information

PackagingFoil bag /bottle

Productivity500 grams per month

TransportationLand,Air,Express,Ocean

Place of Originchina

Supply Ability500grams/month

CertificateN/A

HS Code2934993000

PortShanghai,Shenzhen,Guangzhou

Payment TypeT/T,Paypal

IncotermFOB

Packaging & Delivery
Selling Units:
Gram
Package Type:
Foil bag /bottle
Name: Carfilzomib Other Name: PR-171 Appearance: White Powder Molecular Formula: C40H57N5O7 Molecular Weight:  719.91 CAS-Number: 868540-17-4 Purity >98%. Storage Temp.: 2~8ºC Source: synthetic Carfilzomib, sold under the brand name Kyprolis, is an anti-cancer medication acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin. It was developed by Onyx Pharmaceuticals. The U.S. Food and Drug...

Product Categories : Key Intermediates

Email to this supplier
  • *Subject:
  • *To:
    Ms. Caroline
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
Send Inquiry
*
*

HomeProductsKey IntermediatesAnti-Myeloma Carfilzomib Powder CAS 868540-17-4
Related Products List

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send